Rhubarb

Rheum palmatum

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Rhubarb, covering 2010-05-28 to 2018-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Rhubarb and Angiotensin Converting Enzyme Inhibitor [Phase 2]